ASCO GU 2025

ASCO GU 2025
February 13-15, 2025
San Francisco, CA

American Society of Clinical Oncology Genitourinary Cancers Symposium 2025 .

Explore more information for Gilead Oncology therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (2)

    Sociodemographic disparities in treatment patterns and clinical outcomes among real-world patients with locally advanced/metastatic urothelial carcinoma in the US

    • Author(s): Tawagi, K
    • trodelvy
    • Oncology
    • Trodelvy
    • Sacituzumab
    • SG
    • mUC
    • Urothelial

    Retrospective, observational analysis of real-world safety outcomes in sacituzumab govitecan-treated patients with locally advanced/metastatic urothelial cancer

    • Author(s): Parikh, M
    • trodelvy
    • Oncology
    • Trodelvy
    • SG
    • mUC
    • Urothelial